Ann: Wisr Starts Q2FY21 with Record New Loan Originations, page-48

Very good report for Wisr .

Sorry this is all a bit off - topic . In answer to above : @tinhat —
I thought the same re PNV and unfortunately I was never aboard - but that it looks / looked way over- priced , high high market cap now

versus - I did some actual research.

I think PNV goes higher and onwards . That they can use the treatment for applications from diabetic non- healing sores ( which were high risk , would lead to amputations normally. Becoming fully non- ambulatory . Parasthesia extremities etc . )
And the Polynovo spray can protective , gives a barrier in place of skin which is gone ,& applied to burns victims now who have had ~ 99% , over 95% of their bodies , and they live as result ! When I went through , it was a known that anyone with burns over a greater than 50% of body most likely die due to infection a few weeks later & family and person would be prepared to accept their own inevitable death
There is possible gynae surgery applications instead of where has been world class action against former J&J pelvic mesh synthetic solutions. (PNO treatment just gets absorbed by the body and ‘disappears ‘? )
I had no idea about it and only did a tiny amount of research.
I think PNO goes higher and on still now. ( I do not own and have never owned . I’m almost talking myself into it I think WZR is a much simpler Buy !

The biggest thing -is Backing . Who are the major shareholders , if they are really solid ( maybe folllow them ) , and the financial backing for growth and ongoing .
NAB backs , provide funds for Wisr as I understand it ?
All the best.